News

StimuSIL Unveils New Review on Non-Drug Treatments for Hair Loss 

Physical Therapies and Treatments for Androgenetic Alopecia in the Journal of Clinical Medicine (MDPI)

StimuSIL Introduces StimuField: A New Hair and Scalp Health Wearable

A man wearing a black cap with his head bent

Watch StimuSIL’s Webinar, Featuring Co-Founder Pablo Villalba and CMO Dr. Scott Gerrish

Online webinar with Dr. Scott Gerrish, CMO, and Pablo Villalba, Co-Founder

Follicle Thought Featured StimuSIL in ‘SAGA-001: A New Paradigm in Laser Therapy for Hair Loss’

Follicle Thought's Logo

Read Dr. Marketing’s Feature on Pablo Villalba, ‘From 8Fit to StimuSIL’ 

Podcast with Doctor Marketing's CEO, Alberto Enguita, and Pablo Villalba, Cofounder of StimuSIL

Mira ‘De 8Fit a StimuSIL’, con Dr. Marketing’s Alberto Enguita y Pablo Villalba

Online conference with Doctor Marketing's CEO, Alberto Enguita, and Pablo Villalba, Cofounder of StimuSIL

StimuSIL Announces Their First Patient’s Enrollment in SAGA-001 Clinical Trial

ClinicalTrials.gov registration, stating clinical trials PRS number NCT05970809 and title "Assessing the Safety and Efficacy of a Novel Microneedling and Laser Device for Male Pattern Hair Loss"

Escucha el Podcast de los BioEmprendedores, con Co-Fundador Pablo Villalba

BioEmprendedores Podcast featuring Pablo Villalba in 'The StimuSIL Case'

StimuSIL Presents at Octane’s Aesthetics Tech Forum 2023 

Pablo Villalba speaking at Octane Aesthetics Tech Forum 2023

StimuSIL Welcomes New Engineers to its Growing Team

StimuSIL's new engineers, Dr. Siddhi Camila Lama and Guillermo Cantalapiedra Pro

StimuSIL Launches With a Strategic Investment by GEN

GEN's logo

Get in Touch

Press or media enquiries? Questions for us? Use the contact button below. We’re just one click away.